The HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2
J. Natalie Howard(George Washington University), Alberto Bosque(George Washington University)
Cited by 3
Related Papers
Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
|JCI Insight|2018|78
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells
|PLoS Pathogens|2024|6
The HIV latency reversal agent HODHBt enhances NK Cell effector and memory-like functions by increasing IL-15 mediated-STAT activation
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2